Logo for Initiator Pharma

Initiator Pharma Investor Relations Material

Latest events

Logo for Initiator Pharma

Q4 2023

23 Feb, 2024
Logo for Initiator Pharma

Q3 2023

10 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Initiator Pharma

Access all reports
Initiator Pharma A/S is a clinical stage life science company developing drugs targeting unmet medical needs within the central and peripheral nervous system. The company's pipeline includes IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for treating severe neuropathic pain. In pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain and IPDP2015 for depression. Founded in 2016, Initiator Pharma A/S operates an R&D center in Copenhagen, Denmark.